Skip to main content

Accelerating Regenerative Medicine

Follow RegMed XB on LinkedIn
  • Upcoming events

    Banner DCVA RegMed XB Community Event

    DCVA & RegMed XB Community Event

    For academic researchers and healthcare innovators interested in valorization, entrepreneurship, and accelerating from lab to patient.

    read more
    Banner AC26

    RegMed XB Annual Conference 2026

    Be part of the 4th RegMed XB Annual Conference: Collaborate to Regenerate. Get inspired and expand your network within the regenerative medicine field.

    read more
  • Expertise

    Business Development & Valorization

    Accelerating Innovation in Regenerative Medicine

    read more

    Research Excellence: Moonshots

    Push the boundaries of research excellence

    read more

    Infrastructure: RegMed XB's Pilot Factory

    A seamless pathway for innovators to accelerate, de-risk, and scale regenerative therapies

    read more

    Public-Private Entrepreneurship

    Building ecosystems through collaboration

    read more

    Seed Capital

    Secure early-stage funding

    read more
  • Latest news

    Save 10-11june AC

    Save the date! RegMed XB 4th Annual Conference

    Save the Date! Join us for an exciting community event on June 10th and 11th, covering the entire spectrum of regenerative medicine, from cutting-edge research to practical solutions.

     

    read more
    TTT logo's

    Thematic Tech Transfer (TTT) Program Awarded

    DCVA (Dutch Cardiovascular Alliance), RegMed XB, BioGeneration Ventures (BGV) and its fund FIRST proudly announce that their joint Thematic Tech Transfer (TTT) program has been awarded €10 million in funding by the Netherlands Enterprise Agency (RVO), on behalf of the Ministry of Economic Affairs.

    read more
    Cureon Opening SBMC

    Smart BioMaterials Consortium (SBMC) Opens Cureon Production Facility in Eindhoven

    On October 1, 2025, in front of a full house, Cureon – the new Innovation Center for MedTech and BioTech – officially opened its doors at High Tech Campus Eindhoven. The initiative, driven by High Tech Campus Eindhoven, Smart BioMaterials Consortium (SBMC), Brainport Development, and Brabant Development Agency (BOM), marks a major step forward for healthcare innovation in the region.

    read more
  • Moonshots (research excellence)

    Cardiovascular Moonshot

    Regeneration of the human heart

    read more

    Diabetes Moonshot

    A proof-of-concept therapy for Type 1 Diabetes

    read more

    Kidney Moonshot

    The first subunit of a bio-engineered kidney

    read more

    Osteoarthritis Moonshot

    The road to a bio-artificial joint

    read more
  • Pilot Factory (infrastructure)

    The RegMed XB Pilot Factory is one of the largest international infrastructures for regenerative medicine. It brings together all the expertise and infrastructure needed to bring regenerative medicine to the market.

    Pilot Factory

  • RegMed XB's Ecosystem

    Health Foundations

    The following Dutch health foundations are involved in defining research objectives and provide guidance in the research we conduct to ensure we maintain focus on the patient.

    read more

    Academic Partners

    RegMed XB works together with (inter)national top-rated academic institutions and collaborates specifically and exclusively with researchers who contribute specific expertise to the Moonshot initiatives.

    read more

    Industrial Partners

    Partnering with companies offers access to their expertise in designing scalable and feasible products. Currently, we have strong partnerships with the following entities.

    read more

    Governmental Partners

    RegMed XB receives support from national and local governments to de-risk promising concepts from academia to proof of concept or initial clinical trial stages.

    read more

    Life Science & Health partners

    The following Life Science & Health (LSH) partners are collaborate with RegMed XB.

    read more